Rajat J. Kudchadker, Ph.D., DABR

Peer-Reviewed Articles

1. Grover S, Lichter KE, Likhacheva A, Jang JW, Ning MS, Robin TP, Small W, Kudchadker RJ, Swamidas J, Chopra S, Rai B, Sharma SD, Sharma DN, Kuppusamy T, Yang R, Berger D, Mendez LC, Glaser S, Erickson DL, Chino J, Mourtada F, Abdel-Wahab M, Jhingran A, Simonds H, Mahantshetty U. The American brachytherapy society and Indian Brachytherapy society consensus statement for the establishment of high-dose rate brachytherapy programs for gynecological malignancies in low-and middle-income countries. Brachytherapy. e-Pub 2023. PMID: 37704540.
2. Sanders JW, Tang C, Kudchadker RJ, Venkatesan AM, Mok H, Hanania AN, Thames HD, Bruno TL, Starks C, Santiago E, Cunningham M, Frank SJ. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry. Brachytherapy. e-Pub 2023. PMID: 37716820.
3. Lukka HR, Deshmukh S, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M, Feng FY, Pugh SL, Sandler HM, Kachnic LA. Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. Int J Radiat Oncol Biol Phys 116(4):770-778, 2023. e-Pub 2022. PMID: 36592721.
4. Moreno A, Solanki AA, Xu T, et al. Identification of key elements in prostate cancer for ontology building via a multidisciplinary consensus agreement. Cancers (Basel), 2023.
5. Gao S, Muruganandham M, Du W, Ohrt J, Kudchadker RJ, Balter PA. Adding customized electron energy beams to TrueBeam linear accelerators. J Appl Clin Med Phys 23(7):e13633, 2022. e-Pub 2022. PMID: 35533212.
6. Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno TL, Thames HD, Kudchadker RJ, Frank SJ. Computer-aided segmentation on MRI for prostate radiotherapy, part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry. Radiother Oncol 169:124-131, 2022. e-Pub 2021. PMID: 34921895.
7. Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno TL, Thames HD, Kudchadker RJ, Frank SJ. Computer-aided segmentation on MRI for prostate radiotherapy, part II - Comparing human and computer observer populations and the influence of annotator variability on algorithm variability. Radiother Oncol 169:132-139, 2022. e-Pub 2021. PMID: 34979213.
8. Sanders JW, Kudchadker RJ, Tang C, Mok H, Venkatesan AM, Thames HD, Frank SJ. Prospective Evaluation of Prostate and Organs at Risk Segmentation Software for MRI-based Prostate Radiation Therapy. Radiol Artif Intell 4(2):e210151, 2022. e-Pub 2022. PMID: 35391775.
9. Thaker NG, Kudchadker RJ, Incalcaterra JR, Bathala TK, Kaplan RS, Agarwal A, Kuban DA, Frank BD, Das P, Feeley TW, Frank SJ. Improving efficiency and reducing costs of MRI-guided prostate brachytherapy using time-driven activity-based costing. Brachytherapy 21(1):49-54, 2022. e-Pub 2021. PMID: 34389265.
10. Sanders JW, Venkatesan AM, Levitt CA, Bathala T, Kudchadker RJ, Tang C, Bruno TL, Starks C, Santiago E, Wells M, Weaver CP, Ma J, Frank SJ. Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study. Int J Radiat Oncol Biol Phys 109(2):614-625, 2021. e-Pub 2020. PMID: 32980498.
11. Pollard-Larkin JM, Briere TM, Kudchadker RJ, Sadagopan R, Nitsch PL, Wang XA, Salehpour M, Wang J, Vedam S, Nelson CL, Sahoo N, Zhu XR, Court LE, Balter PA, Robinson IJ, Yang J, Howell RM, Followill DS, Kry S, Beddar SA, Martel MK. Our Experience Leading a Large Medical Physics Practice During the COVID-19 Pandemic. Adv Radiat Oncol 6(4):100683, 2021. e-Pub 2021. PMID: 33824935.
12. Sanders JW, Lewis GD, Thames HD, Kudchadker RJ, Venkatesan AM, Bruno TL, Ma J, Pagel MD, Frank SJ. Machine segmentation of pelvic anatomy in MRI-assisted radiosurgery (MARS) for prostate cancer brachytherapy. Int J Radiat Oncol Biol Phys 108(5):1292-1303, 2020. e-Pub 2020. PMID: 32634543.
13. Mesko S, Chapman BV, Tang C, Kudchadker RJ, Bruno TL, Sanders J, Das P, Pinnix CC, Thaker NG, Frank SJ. Development, implementation, and outcomes of a simulation-based medical education (SBME) prostate brachytherapy workshop for radiation oncology residents. Brachytherapy 19(6):738-745, 2020. e-Pub 2020. PMID: 32952054.
14. Frank SJ, Mourtada F, Crook J, Orio PF, Stock RG, Petereit DG, Rossi PJ, Cox BW, Tang C, Kudchadker RJ, Bruno T, Ma J, Sanders J, Keyes M. The American Brachytherapy Society Prostate Brachytherapy LDR/HDR Simulation Workshops: Hands-on, Step-by-Step Training in the Process of Quality Assurance. Brachytherapy 19(6):787-793, 2020. e-Pub 2020. PMID: 33132070.
15. Boyce-Fappiano D, Bathala TK, Ye R, Pasalic D, Gjyshi O, Pezzi TA, Noticewala SS, McGinnis GJ, Maroongroge S, Kuban DA, Nguyen QN, McGuire SE, Hoffman KE, Choi S, Tang C, Kudchadker RJ, Frank SJ. Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy. Brachytherapy 19(5):574-583, 2020. e-Pub 2020. PMID: 32682778.
16. Bathala TK, Venkatesan AM, Ma J, Bhosale P, Wei W, Kudchadker RJ, Wang J, Anscher MS, Tang C, Bruno TL, Frank SJ, Szklaruk J. Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy. Brachytherapy 19(4):484-490, 2020. e-Pub 2020. PMID: 32402544.
17. Hanania AN, Kudchadker RJ, Bruno TL, Tang C, Anscher MS, Frank SJ. MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy. Brachytherapy 19(1):38-42, 2020. e-Pub 2019. PMID: 31812590.
18. Pasalic D, Prajapati S, Ludmir EB, Tang C, Choi S, Kudchadker R, Frank SJ. Outcomes and Toxicities of Proton and Photon Radiation Therapy for Testicular Seminoma. Int J Part Ther 7(2):11-20, 2020. e-Pub 2020. PMID: 33274253.
19. Sanders J, Fletcher J, Frank S, Liu HL, Johnson J, Zhou Z, Chen HSC, Venkatesan A, Kudchadker R, Pagel M, Ma J. Deep learning application engine (DLAE): Development and integration of deep learning algorithms in medical imaging. Software X 10:100347, 2019. e-Pub 2019.
20. Sanders JW, Frank SJ, Kudchadker RJ, Bruno TL, Ma J. Development and clinical implementation of SeedNet: A sliding-window convolutional neural network for radioactive seed identification in MRI-assisted radiosurgery (MARS). Magn Reson Med 81(6):3888-3900, 2019. e-Pub 2019. PMID: 30737827.
21. Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA. Patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer. Int J Radiat Oncol Biol Phys 102(2):287-295, 2018. e-Pub 2018. PMID: 29913254.
22. Hoffman KE, Voong KR, Levy LB, Allen PK, Choi S, Schlembach PJ, Lee AK, McGuire SE, Nguyen Q, Pugh TJ, Frank SJ, Kudchadker RJ, Du W, Kuban DA. Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer. J Clin Oncol 36(29):2943-2949, 2018. e-Pub 2018. PMID: 30106637.
23. Du W, Gao S, Jiang W, Kudchadker RJ. Independent evaluation of the effectiveness of IsoCal in improving image center accuracy on Varian TrueBeam and Clinac machines. J Appl Clin Med Phys 19(5):483-490, 2018. e-Pub 2018. PMID: 29956463.
24. Hoffman KE, Skinner H, Pugh TJ, Voong KR, Levy LB, Choi S, Frank SJ, Lee AK, Mahmood U, McGuire SE, Schlembach PJ, Du W, Johnson J, Kudchadker RJ, Kuban DA. Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial. Am J Clin Oncol 41(6):558-567, 2018. e-Pub 2016. PMID: 27635624.
25. Yan Y, Yang J, Beddar S, Ibbott G, Wen Z, Court LE, Hwang KP, Kadbi M, Krishnan S, Fuller CD, Frank SJ, Yang J, Balter P, Kudchadker RJ, Wang J. A Methodology to Investigate the Impact of Image Distortions on the Radiation Dose When Using Magnetic Resonance Images for Planning. Phys Med Biol 63(8):085005, 2018. e-Pub 2018. PMID: 29528037.
26. Martin GV, Kudchadker RJ, Bruno TL, Frank SJ, Wang J. Comparison of prostate distortion by inflatable and rigid endorectal MRI coils in permanent prostate brachytherapy imaging. Brachytherapy 17(2):298-305, 2018. e-Pub 2017. PMID: 29169971.
27. Blanchard P, Pugh TJ, Swanson DA, Mahmood U, Chen HC, Wang X, Graber WJ, Kudchadker RJ, Bruno T, Feeley T, Frank SJ. Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study. Brachytherapy 17(2):265-276, 2018. e-Pub 2017. PMID: 29269207.
28. Alsanea F, Wootton L, Sahoo N, Kudchadker R, Mahmood U, Beddar S. Exradin W1 plastic scintillation detector for in vivo skin dosimetry in passive scattering proton therapy. Phys Med 47:58-63, 2018. e-Pub 2018. PMID: 29609819.
29. Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, Wang X, Swanson DA. Prospective phase 2 trial of permanent seed implantation prostate brachytherapy for intermediate-risk localized prostate cancer: efficacy, toxicity, and quality of life outcomes. Int J Radiat Oncol Biol Phys 100(2):374-382, 2018. e-Pub 2017. PMID: 29229325.
30. Ma J, Moerland MA, Venkatesan AM, Bathala TK, Kudchadker RJ, Brock KK, Frank SJ. Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy. Brachytherapy 16(4):743-753, 2017. e-Pub 2017. PMID: 28063817.
31. Martin GV, Pugh TJ, Mahmood U, Kudchadker RJ, Wang J, Bruno TL, Bathala T, Frank SJ. Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imaging. Brachytherapy 16(4):728-733, 2017. e-Pub 2017. PMID: 28284511.
32. Jackson MW, Amini A, Jones BL, Kavanagh B, Maroni P, Frank SJ, Mahmood U, Kudchadker RJ, Pugh TJ. Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason Score 8) prostate cancer. Brachytherapy 16(4):790-796, 2017. e-Pub 2017. PMID: 28442277.
33. Wang J, Tanderup K, Cunha A, Damato AL, Cohen GN, Kudchadker RJ, Mourtada F. Magnetic resonance imaging basics for the prostate brachytherapist. Brachytherapy 16(4):715-727, 2017. e-Pub 2017. PMID: 28396178.
34. Cardenas CE, Nitsch PL, Kudchadker RJ, Howell RM, Kry SF. Out-of-field doses and neutron dose equivalents for electron beams from modern Varian and Elekta linear accelerators. J Appl Clin Med Phys 17(4):442-455, 2016. e-Pub 2016. PMID: 27455499.
35. Lim TY, Kudchadker RJ, Wang J, Stafford RJ, MacLellan C, Rao A, Ibbott GS, Frank SJ. Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment. Med Phys 43(7):4312-4322, 2016. PMID: 27370146.
36. Lim TY, Kudchadker RJ, Wang J, Bathala T, Szklaruk J, Pugh TJ, Mahmood U, Ibbott GS, Frank SJ. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience. J Contemp Brachytherapy 8(3):235-242, 2016. e-Pub 2016. PMID: 27504133.
37. Thaker NG, Pugh TJ, Mahmood U, Choi S, Spinks TE, Martin NE, Sio TT, Kudchadker RJ, Kaplan RS, Kuban DA, Swanson DA, Orio PF, Zelefsky MJ, Cox BW, Potters L, Buchholz TA, Feeley TW, Frank SJ. Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing. Brachytherapy 15(3):274-282, 2016. e-Pub 2016. PMID: 26916105.
38. Du W, Johnson JL, Jiang W, Kudchadker RJ. On the selection of gantry and collimator angles for isocenter localization using Winston-Lutz tests. J Appl Clin Med Phys 17(1):167-178, 2016. e-Pub 2016. PMID: 26894350.
39. Yu ZH, Kudchadker R, Dong L, Zhang Y, Court LE, Mourtada F, Yock A, Tucker SL, Yang J. Learning anatomy changes from patient populations to create artificial CT images for voxel-level validation of deformable image registration. J Appl Clin Med Phys 17(1):246-258, 2016. e-Pub 2016. PMID: 26894362.
40. Dhanesar SK, Lim TY, Du W, Bruno TL, Frank SJ, Kudchadker RJ. Evaluation of the MIM Symphony treatment planning system for low dose rate prostate brachytherapy. J Appl Clin Med Phys 16(5):62-75, 2015. e-Pub 2015. PMID: 26699290.
41. Pugh TJ, Mahmood U, Swanson DA, Munsell MF, Wang R, Kudchadker RJ, Bruno TL, Frank SJ. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil. Brachytherapy 14(2):160-165, 2015. e-Pub 2014. PMID: 25255712.
42. Thaker NG, Kudchadker RJ, Swanson DA, Albert JM, Mahmood U, Pugh TJ, Boehling NS, Bruno TL, Prestidge BR, Crook JM, Cox BW, Potters L, Moran BJ, Keyes M, Kuban DA, Frank SJ. Establishing high quality prostate brachytherapy using a phantom simulator training program. Int J Radiat Oncol Biol Phys 90(3):579-586, 2014. e-Pub 2014. PMID: 25151539.
43. Wang J, Kudchadker R, Choi S, Pettaway CA, Choi H, Hobbs BD, Occena MC, McGuire SE, Pugh TJ, Hoffman K, Mahmood U, Kuban DA. Local recurrence map to guide target volume delineation after radical prostatectomy. Pract Radiat Oncol 4(6):e239-e246, 2014. e-Pub 2014. PMID: 25407875.
44. Yock AD, Rao A, Dong L, Beadle BM, Garden AS, Kudchadker RJ, Court LE. Forecasting longitudinal changes in oropharyngeal tumor morphology throughout the course of head and neck radiation therapy. Med Phys 41(8):081708, 2014. e-Pub 2014. PMID: 25086518.
45. Yock AD, Rao A, Dong L, Beadle BM, Garden AS, Kudchadker RJ, Court LE. Predicting oropharyngeal tumor volume throughout the course of radiation therapy from pre-treatment computed tomography data using general linear models. Med Phys 41(5):051705, 2014. PMID: 24784371.
46. Lim TY, Stafford RJ, Kudchadker RJ, Sankaranarayanapillai M, Ibbott G, Rao A, Martirosyan KS, Frank SJ. MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy. Med Phys 59(10):2505-2516, 2014. e-Pub 2014. PMID: 24778352.
47. Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial. Int J Radiat Oncol Biol Phys 88(5):1074-1084, 2014. e-Pub 2014. PMID: 24661661.
48. Gossman MS, Hancock SS, Kudchadker RJ, Lundahl PR, Cao M, Melhus CS. Brachytherapy dose-volume histogram commissioning with multiple planning systems. J Appl Clin Med Phys 15(2):110-120, 2014. e-Pub 2014. PMID: 24710449.
49. Wootton L, Kudchadker R, Lee A, Beddar S. Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer. Phys Med Biol 59(3):647-660, 2014. e-Pub 2014. PMID: 24434775.
50. Du W, Cho SH, Zhang X, Hoffman KE, Kudchadker RJ. Quantification of beam complexity in intensity-modulated radiation therapy treatment plans. Med Phys 41(2):021716, 2014. PMID: 24506607.
51. Takiar V, Pugh TJ, Swanson D, Kudchadker RJ, Bruno TL, McAvoy S, Mahmood U, Frank SJ. MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer. Brachytherapy 13(1):68-74, 2014. e-Pub 2013. PMID: 23669149.
52. Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA. Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients. Prostate Cancer Prostatic Dis 16(4):346-351, 2013. e-Pub 2013. PMID: 23939133.
53. Melancon AD, Kudchadker RJ, Amos R, Johnson JL, Zhang Y, Yu ZH, Zhang L, Dong L. Patient-specific and generic immobilization devices for prostate radiotherapy. Int J of Med Phys Clin Engr and Radiat Oncol 2(4):125-132, 2013.
54. Melancon AD, Lee AK, Kudchadker R, Zhang L, Tucker SL, Kuban D, Dong L. Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer. Pract Radiat Oncol 3(4):329-336, 2013. e-Pub 2012. PMID: 24674406.
55. Brown AP, Pugh TJ, Swanson DA, Kudchadker RJ, Bruno TL, Christensen EN, van Vulpen M, Frank SJ. Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer. Brachytherapy 12(5):401-407, 2013. e-Pub 2013. PMID: 23380383.
56. Li X, Quan EM, Li Y, Pan X, Zhou Y, Wang X, Du W, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X. A Fully Automated Method for CT-on-Rails-Guided Online Adaptive Planning for Prostate Cancer Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 86(5):835-841, 2013. e-Pub 2013. PMID: 23726001.
57. Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE, Swanson DA, Kudchadker R, Davis JW. Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy. Brachytherapy 12(3):204-209, 2013. e-Pub 2012. PMID: 22673704.
58. Register SP, Kudchadker RJ, Levy LB, Swanson DA, Pugh TJ, Bruno TL, Frank SJ. An MRI-based dose-response analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a Phase II Prospective Trial. Brachytherapy 12(3):210-216, 2013. e-Pub 2013. PMID: 23466360.
59. Cheung JP, Park PC, Court LE, Ronald Zhu X, Kudchadker RJ, Frank SJ, Dong L. A novel dose-based positioning method for CT image-guided proton therapy. Med Phys 40(5):051714, 2013. e-Pub 2013. PMID: 23635262.
60. Albert JM, Swanson DA, Pugh TJ, Zhang M, Bruno TL, Kudchadker RJ, Frank SJ. Magnetic resonance imaging-based treatment planning for prostate brachytherapy. Brachytherapy 12(1):30-37, 2013. e-Pub 2012. PMID: 22727474.
61. McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA. PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose escalated radiation therapy era. Int J Radiat Oncol Biol Phys 85(1):e39-e46, 2013. e-Pub 2012. PMID: 23102837.
62. Pair ML, Du W, Rojas HD, Kanke JE, McGuire SE, Lee AK, Kuban DA, Kudchadker RJ. Dosimetric effects of weight loss or gain during volumetric-modulated arc therapy and intensity-modulated radiation therapy for prostate cancer. Med Dosim 38(3):251-254, 2013. e-Pub 2013. PMID: 23540491.
63. Klein D, Briere TM, Kudchadker R, Archambault L, Beaulieu L, Lee A, Beddar S. In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors. Radiat Meas 47(10):921-929, 2012. e-Pub 2012. PMID: 23180976.
64. Wootton LS, Kudchadker RJ, Beddar AS, Lee AK. Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy. J Appl Clin Med Phys 13(5):190-197, 2012. e-Pub 2012. PMID: 22955660.
65. Vassiliev ON, Kudchadker RJ, Kuban DA, Frank SJ, Choi S, Nguyen Q, Lee AK. Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy. Phys Med 28(3):240-244, 2012. e-Pub 2011. PMID: 21875820.
66. Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys 83(4):1169-1178, 2012. PMID: 22704703.
67. Sharp HJ, Swanson DA, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Frank SJ. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Pract Radiat Oncol 2(3):e7-e13, 2012. e-Pub 2012. PMID: 24674130.
68. Whaley JT, Levy LB, Swanson DA, Pugh TJ, Kudchadker RJ, Bruno TL, Frank SJ. Sexual Function and the use of Medical Devices or Drugs to Optimize Potency after Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 82(5):e765-e771, 2012. e-Pub 2012. PMID: 22300559.
69. Du W, Gao S, Wang X, Kudchadker RJ. Quantifying the gantry sag on linear accelerators and introducing an MLC-based compensation strategy. Med Phys 39(4):2156-2162, 2012. PMID: 22482636.
70. Kim MM, Kudchadker RJ, Kanke JE, Zhang S, Perkins GH. Bolus electron conformal therapy for the treatment of recurrent inflammatory breast cancer: A case report. Med Dosim 37(2):208-213, 2012. e-Pub 2011. PMID: 21978532.
71. Kudchadker RJ, Pugh TJ, Swanson DA, Bruno TL, Bolukbasi Y, Frank SJ. Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy. Med Dosim 37(4):387-390, 2012. e-Pub 2012. PMID: 22560295.
72. Samuelian JM, Swanson DA, Kudchadker RJ, Pugh TJ, Kuban DA, Lee AK, Choi S, Nguyen QN, Bruno TL, Frank SJ. Long-term tumor control after brachytherapy for base of prostate cancer. J Contemp Brachytherapy 3(4):183-187, 2011. e-Pub 2011. PMID: 23346126.
73. Vassiliev ON, Kudchadker RJ, Swanson DA, Bruno TL, van Vulpen M, Frank SJ. Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy. Brachytherapy 10(5):401-408, 2011. e-Pub 2011. PMID: 21306959.
74. Huang JY, Newhauser WD, Zhu XR, Lee AK, Kudchadker RJ. Investigation of dose perturbations and the radiographic visibility of potential fiducials for proton radiation therapy of the prostate. Phys Med Biol 56(16):5287-5302, 2011. e-Pub 2011. PMID: 21799236.
75. Shirvani SM, Kudchadker RJ, Bruno TL, Likhacheva A, Swanson DA, Frank SJ. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125. Brachytherapy 10(4):269-274, 2011. e-Pub 2011. PMID: 21296031.
76. Li H, Lee AK, Johnson JL, Zhu RX, Kudchadker RJ. Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches. J Appl Clin Med Phys 12(3):23-31, 2011. e-Pub 2011. PMID: 21844859.
77. Frank SJ, Tailor RC, Kudchadker RJ, Martirosyan KS, Stafford RJ, Elliott AM, Swanson DA, Sing D, Choi J, Mourtada F, Ibbott GS. Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy. Med Dosim 36(2):200-205, 2011. e-Pub 2010. PMID: 20537886.
78. Sha RL, Reddy PY, Rao R, Muralidhar KR, Kudchadker RJ. Evaluation of rectal dose during high-dose rate intracavitary brachytherapy for cervical carcinoma. Med Dosim 36(4):377-382, 2011. e-Pub 2010. PMID: 21144733.
79. Kry SF, Johnson JL, White RA, Howell RM, Kudchadker RJ, Gillin MT. Neutron-induced electronic failures around a high-energy linear accelerator. Med Phys 38(1):34-39, 2011. e-Pub 2011. PMID: 21361172.
80. Cheung J, Kudchadker RJ, Zhu XR, Lee AK, Newhauser WD. Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer. Phys Med Biol 55(23):7135-7147, 2010. e-Pub 2010. PMID: 21076190.
81. Frank SJ, Kudchadker RJ, Kuban DA, De Crevoisier R, Lee AK, Cheung RM, Choi S, Tucker SL, Dong L. A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity modulated radiation therapy. Am J Clin Oncol 33(2):173-175, 2010. PMID: 20010077.
82. Zullo JR, Kudchadker RJ, Zhu XR, Sahoo N, Gillin MT. LiF TLD-100 as a dosimeter in high energy proton beam therapy - Can it yield accurate results?. Med Dosim 35(1):63-66, 2010. e-Pub 2009. PMID: 19931017.
83. Brooks C, Cheung RM, Kudchadker RJ. Intensity-modulated radiation therapy with noncoplanar beams for treatment of prostate cancer in patients with bilateral hip prosthesis-a case study. Med Dosim 35(2):87-91, 2010. e-Pub 2009. PMID: 19931019.
84. Sejpal SV, Amos RA, Bluett JB, Levy LB, Kudchadker RJ, Johnson J, Choi S, Lee AK. Dosimetric Changes Resulting From Patient Rotational Setup Errors in Proton Therapy Prostate Plans. Int J Radiat Oncol Biol Phys 75(1):40-48, 2009. e-Pub 2008. PMID: 19058919.
85. Anderson JF, Swanson DA, Levy LB, Kuban DA, Lee AK, Kudchadker R, Phan J, Bruno T, Frank SJ. Urinary Side Effects and Complications After Permanent Prostate Brachytherapy: The MD Anderson Cancer Center Experience. Urology 74(3):601-605, 2009. e-Pub 2009. PMID: 19589580.
86. Kudchadker RJ, Lee AK, Yu ZH, Johnson JL, Zhang L, Zhang Y, Amos RA, Nakanishi H, Ochiai A, Dong L. Effectiveness of using fewer implanted fiducial markers for prostate target alignment. Int J Radiat Oncol Biol Phys 74(4):1283-1289, 2009. e-Pub 2009. PMID: 19427750.
87. Phan J, Swanson DA, Levy LB, Kudchadker RJ, Bruno TL, Frank SJ. Late Rectal Complications after prostate brachytherapy for localized prostate cancer: Incidence and Management. Cancer 115(9):1827-1839, 2009. e-Pub 2009. PMID: 19248043.
88. Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, Bruno TL, van Vulpen M, Swanson DA. Prostogram-predicted brachytherapy outcomes may not be universally accurate: An analysis based on the M.D. Anderson Cancer Center experience with Iodine-125 brachytherapy. J Urol 181(4):1658-1663, 2009. e-Pub 2009. PMID: 19233434.
89. Weinberg R, Antolak JA, Starkschall G, Kudchadker RJ, White RA, Hogstrom KR. Influence of source parameters on large-field electron beam profiles calculated using Monte Carlo methods. Phys Med Biol 54(1):105-116, 2009. e-Pub 2008. PMID: 19075360.
90. Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?. Int J Radiat Oncol Biol Phys 72(2):623-627, 2008. e-Pub 2008. PMID: 18410998.
91. Nelson C, Balter P, Morice RC, Choi B, Kudchadker RJ, Bucci K, Chang JY, Dong L, Tucker S, Vedam S, Briere T, Starkschall G. A technique for reducing patient setup uncertainties by aligning and verifying daily positioning of a moving tumor using implanted fiducials. J Appl Clin Med Phys 9(4):110-122, 2008. e-Pub 2008. PMID: 19020478.
92. Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 71(3):813-820, 2008. e-Pub 2008. PMID: 18207664.
93. O'Daniel JC, Dong L, Zhang L, Wang H, Tucker SL, Kudchadker RJ, Lee AK, Cheung R, Cox JD, Kuban DA, Mohan R. Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy. Int J Radiat Oncol Biol Phys 71(1):274-280, 2008. PMID: 18406891.
94. Frank SJ, Stafford RJ, Bankson JA, Li C, Swanson DA, Kudchadker RJ, Martirosyan KS. A novel MRI marker for prostate brachytherapy. Int J Radiat Oncol Biol Phys 71(1):5-8, 2008. PMID: 18406882.
95. Melancon AD, O'Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, Cheung RM, de Crevoisier R, Tucker SL, Newhauser WD, Mohan R, Dong L. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?. Radiother Oncol 85(2):251-259, 2007. e-Pub 2007. PMID: 17892900.
96. Zullo JR, Kudchadker R, Wu R, Lee A, Prado K. Implication of CT table sag on geometrical accuracy during virtual simulation. Med Dosim 32(4):233-236, 2007. PMID: 17980822.
97. de Crevoisier R, Melancon AD, Kuban DA, Lee AK, Cheung RM, Tucker SL, Kudchadker RJ, Newhauser WD, Zhang L, Mohan R, Dong L. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int J Radiat Oncol Biol Phys 68(5):1529-1536, 2007. e-Pub 2007. PMID: 17544595.
98. Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 67(4):1059-1065, 2007. e-Pub 2007. PMID: 17241755.
99. O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, Kuban DA. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 66(3):883-891, 2006. PMID: 17011461.
100. Kudchadker RJ, Chang EL, Bryan F, Maor MH, Famiglietti R. An evaluation of radiation exposure from portal films taken during definitive course of pediatric radiotherapy. Int J Radiat Oncol Biol Phys 59(4):1229-1235, 2004. PMID: 15234060.
101. Zullo JR, Bloch C, Chi PC, Kudchadker R. Linearity and uniformity response as an indicator of performance for Agfa ADC-MD10 computed radiography plates. Med Dosim 29(2):118-121, 2004. PMID: 15191759.
102. Kirsner SM, Kudchadker RJ, Prado KL, Ha CS, Wilder RB, Cox JD. Clinical implications of incorporating heterogeneity corrections in mantle field irradiation. Int J Radiat Oncol Biol Phys 55(4):1135-1142, 2003. PMID: 12605993.
103. Kudchadker RJ, Antolak JA, Morrison WH, Wong PF, Hogstrom KR. Utilization of custom electron bolus in head and neck radiotherapy. J Appl Clin Med Phys 4(4):321-333, 2003. PMID: 14604422.
104. Prado KL, Kirsner SM, Kudchadker RJ, Steadham RE, Lane RG. Enhanced dynamic wedge factors at off-axis points in asymmetric fields. J Appl Clin Med Phys 4(1):75-84, 2003. PMID: 12540821.
105. Kudchadker RJ, Hogstrom KR, Garden AS, McNeese MD, Boyd RA, Antolak JA. Electron conformal radiotherapy using bolus and intensity modulation. Int J Radiat Oncol Biol Phys 53(4):1023-1037, 2002. PMID: 12095572.
106. Lee CL, Zhou XL, Kudchadker RJ, Harmon F, Harker YD. A Monte Carlo dosimetry-based evaluation of the 7Li(p,n)7Be reaction near threshold for accelerator boron neutron capture therapy. Med Phys 27(1):192-202, 2000. PMID: 10659757.
107. Kudchadker RJ, Hogstrom KR, Boyd RA. Multileaf collimation for electron intensity modulation. IEEE Engineering in Medicine and Biology 1:210-213, 2000.
108. Lee C, Zhou X, Harmon F, Bartholomay R, Harker Y, Kudchadker RJ. Thermal neutron flux mapping in a head phantom. Nuclear Instruments and Methods 422(1-3):106-10, 1999.
109. Katlowitz, K, Beckham T, Kudchadker RJ, Wefel J, Weinberg JS. A novel multimodal approach to refractory brain metastases: a case report. Advances in Radiation Oncology.
110. Buyyounouski M, Chen R, Mann M, et al. Primary endpoint analysis of a randomized phase III trial of hypofractionated versus conventional post-prostatectomy radiotherapy: NRG oncology GU003. JAMA Oncology.

Invited Articles

1. Kunze J, Harmon F, Kudchadker R, Lee C . Maximizing the Efficacy of Accelerator Produced Neutrons for BNCT. Transactions of the American Nuclear Society 82:117-118, 2000.
2. Kudchadker R, Lee C, Harker Y, Harmon F. Experimental Dosimetry and Beam Evaluation in a Phantom for Near Lithium Threshold Accelerator Based BNCT. Applications of Accelerators in Research and Industry 475(First):1056-1060, 1999. PMID: 1-56396-825-8.
3. Kudchadker R, Harmon F, Kunze J, Bartholomay R, Lee C. An accelerator based epithermal neutron source for BNCT. Proceedings of the 6th International Conference on Nuclear Engineering (ICONE-6):6451-6455, 1998.
4. Kunze J, Kudchadker R, Sandquist G, Slaughter D. The future of nuclear power with respect to health effects of radiation. Proceedings of the 6th International Conference on Nuclear Engineering (ICONE-6), 1998.
5. Kudchadker R, Kunze J, Harmon J . Accelerator designs that balance distance with energy and moderator dimensions. Transactions of the American Nuclear Society 75:23, 1996.
6. Kudchadker R, Setty M. Examination of zirconium titanium oxide systems for thick film oxygen sensors. Proceedings of the Fourth Annual Conference of the International Society of Hybrid Microelectronics 1, 1988.

Manuals, Teaching Aids, Other Teaching Publications

1. Kudchadker RJ. Introduction to Radiation Protection, 2007.
2. Kudchadker RJ. Nuclear Physics Laboratory: Pocatello, ID, 1997.

Other Articles

1. Brooks C, Cheung R, Kudchadker RJ Intensity modulated radiation therapy with non-coplanar beams for treatment of prostate cancer in patients with bilateral hip prostheses - A case study. AAMD Writing Competition, 2007.
2. Kennedy K, Kudchadker R, Lee C Accelerator based therapy sources for rheumatoid arthritis. Proceedings of the National Conference for Undergraduate Research, 1999.
3. Kudchadker R Optimized Accelerator Based Epithermal Neutron Beams for Boron Neutron Capture Therapy. Med Phys 24(7):1182, 1997.

Abstracts

1. Bhim N, Mok H, Tang C, Kudchadker RJ, Choi S, Hoffman K, Bruno T, Frank SJ. Biochemical failure-free survival rates after Brachytherapy with I-125, Pd-103 or Cs-131 for immediate-risk prostate cancer: Phase II trial. Brachytherapy 21(6):S22-S23, 2022.
2. Prajapati S, Simiele SJ, Kudchadker R, Mourtada F. Practical considerations for dosimetric verification of Ru-106 eye plaque vendor certificate using radiochromic film. Brachytherapy 21(6):S24, 2022.
3. Sanders J, Tang C, Kudchadker R, Venkatesan A, Mok H, Hanania A, et al. Interobserver variability of prostate MRI-assisted radiosurgery postimplant dosimetry: Comparison with automatic postimplant dosimetry. Brachytherapy 21(6):S56-S57, 2022.
4. Corrigan K, Prajapati S, Marqueen K, Manzar G, Mok H, Tang C, Kudchadker R, Frank SJ. Assessment of brachytherapy-induced prostate edema on post-implant dosimetric analysis in MRI-Assisted radiosurgery. Brachytherapy 21(6):S58, 2022.
5. Ko, R, Yu, Z, Prajapati S, Lee B, Albert R, Daniel A, et. al. Neuromuscular toxicity and dose-volume relationships following SBRT for bone oligometastases: Post-hoc analysis of two ongoing clinical trials. Int J Radiat Biol Phys 114(3):e428-e429, 2022.
6. Prajapati S, Zhao Y, Tang C, Yu H, Lee B, Castillo P, Sobremonte A, Kudchadker R, Yang J. Comparison of CT-guided and MR-guided adaptive radiotherapy for intramuscular metastasis. Medical Physics, 2022.
7. Prajapati S, Yu Z, Zhao Y, Lim TY, Wang H, Wang X, Lee B, Castillo P, Sobremonte A, Farooqi A, Mitra D, Kudchadker R, Tang C, Yang J. Quantifying setup uncertainties in treating intramuscular metastases with image-guided radiation therapy. Med Phys, 2022.
8. Sanders JW, Mok H, Venkatesan AM, Tang C, Hanania A, Bruno TL, Starks C, Santiago E, Cunningham M, Thames HD, Kudchadker RJ, Frank SJ. Interobserver variability of postimplant dosimetry for MRI-based low-dose-rate prostate brachytherapy. RSNA, 2021.
9. Sanders J, Mok H, Tang C, Hanania A, Venkatesan A, Bruno T, Kudchadker T, Thames HD, Frank SJ. Benchmarking automatic segmentation algorithms against human interobserver variability of prostate and organs at risk delineation on prostate MRI. Int J Rad Onc Biol Phys 111(3S):291-292, 2021. PMID: 34701109.
10. Buyyounouski MK, Pugh SL, Chen RC, Mann MJ, Kudchadker RJ, Konski AA, Mian OY, Michalski JM, Vigneault E, Valicenti RK, Barkati M, Lawton CA, Potters L, Monitto DC, Kittle JA, Schroeder TM, Hanna R, Duncan CE, Rodgers JP, Sandler HM. Primary endpoint analysis of a randomized phase III trial of hypofractionated versus conventional post-prostatectomy radiotherapy: NRG Oncology GU003. Int J Rad Onc Biol Phys 111(3S):2-3, 2021. PMID: 34700507.
11. Weinberg JS, McAleer MF, Johnson JM, Kudchadker RJ, Wefel JS, Yuan Y, Lin HY. A phase III multicenter randomized controlled trial of postsurgical stereotactic radiotherapy versus surgically targeted radiation therapy (STaRT) for the treatment of large (>2.5 cm) newly diagnosed brain metastases: Trial in progress. J Clin Oncol 38(15_suppl):TPS2067, 2021.
12. Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno TL, Thames HD, Kudchadker RJ, Frank SJ. Interobserver variability of target and organ at risk delineation in MRI-based prostate brachytherapy across two anatomical pulse sequences. Brachytherapy 20(3):S43-S44, 2021.
13. Sanders J, Mok H, Levitt CA, Tang C, Kudchadker RJ, Venkatesan A, et al. Autosegmentation in the clinic: Initial experiences with LDR prostate cancer patients from two MRI-based practices. Brachytherapy 20(3):S73, 2021.
14. Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno T, Thames HD, Kudchadker RJ, Frank SJ. Computer Vision Exhibits Entropy Similar to Prostate Cancer Physicians: A Computational Observer Study, 2020.
15. Geng H, Men K, Lukka H, Leath C, Kudchadker R, Lee Y, et al. Evaluation of a deep learning-based auto-segmentation method for quality assurance of both male and female pelvic organ-at-risk contours in NCTN clinical trials. Int J Radiat Biol Phys 108(3):e769, 2020.
16. Lukka H, Deshmukh S, Bruner DW, Bahary JP, Lawton CAF, et al. Patient reported outcomes in NRG oncology/RTOG 0938, a randomized phase II study evaluating 2 ultrahypofractionated regimes (UHR) for prostate cancer (CaP). Int J Radiat Biol Phys 108(3):S119-S120, 2020.
17. Sanders JW, Frank SJ, Venkatesan AM, Bathala T, Tang C, Kudchadker RJ, Bruno TL, Pagel MD, Ma J. Parallel imaging compressed sensing in fully balanced SSFP for prostate brachytherapy MRI without an endorectal coil: a prospective study. ISMRM, 2020.
18. Boyce D, Bathala TK, Chen AC, Kudchadker RJ, Bruno TL, Frank SJ. Longer preoperative membranous urethral length is associated with GU toxicity after permanent prostate brachytherapy. Brachytherapy 18(3S):S76, 2019. e-Pub 2019.
19. Sandres J, Frank S, Lewis G, Kudchadker R, Bruno T, Ma J. Multi-tasking neural networks for anatomy segmentation in prostate brachytherapy MRI. Brachytherapy 18(3):S16, 2019. e-Pub 2019.
20. Hanania AN, Kudchadker RJ, Bruno TL, Anscher MS, Tang C, Frank SJ. An MRI-based nomogram for palladium and iodine prostate brachytherapy quality assurance. Brachytherapy 18(2S):S66, 2019. e-Pub 2019.
21. Thaker N, Pasalic D, Ning MS, Tang C, Anscher MS, Bathala TK, Kudchadker R, Ma J, Frank SJ. Defining the value of MRI-assisted radiosurgery (MARS) for prostate brachytherapy: A pilot study using time-driven activity-based costing. Brachytherapy 18(3S):S80, 2019. e-Pub 2019.
22. Lukka HR, Pugh SL, Bruner DW, et. al. Patient reported outcomes in NRG oncology/RTOG 0938, evaluating two ultrahypofractionated regimes for prostate cancer. Int J Radiat Biol Phys 102(2):287-295, 2018.
23. Farooqi A, Blanchard P, Bruno T, Kudchadker R, Tang C, et al. Early quality of life outcomes and patient satisfaction metrics for MRI-Assisted prostate brachytherapy patients. Int J Radiat Biol Phys 99(2):e230, 2017.
24. Sanders J, Frank S, Venkatesan A, Bathala T, Szklaruk J, Blanchard P, Kudchadker R, Ma J. TrueFISP for single sequence MR-only post-implant dosimetry of prostate brachytherapy. Med Phys 44(6):3049, 2017. e-Pub 2017.
25. Sanders J, Frank S, Bathala T, Venkatesan A, Kudchadker R, Blanchard P, Martin G, Wang J, Berner P, Bruno T, Ma J. MRI-Based prostate brachytherapy - Imaging with and without an endorectal coil for post implant quality assurance. Brachytherapy 16(3S):S56, 2017.
26. Martin GV, Ma J, Kudchadker RJ, Wang J, Bruno TL, Blanchard P, Frank SJ. Automated prostate brachytherapy seed detection post-implant MRI using novel Martin algorithm. Brachytherapy 16(3):S57, 2017.
27. Farooqi A, Blanchard P, Bruno T, Kudchadker RJ, Wang J, Venkatesan A, Bathala T, Ma J, Frank SJ. Early quality of life outcomes for MRI-assisted prostate brachytherapy patients. Brachytherapy 16(3S):S108, 2017.
28. Martin G, Pugh T, Mahmood U, Swanson D, Lim T, Kudchadker R, Graber W, Wang J, Bruno T, Bathala T, Blanchard P, Frank S. Are we Ready to Replace Post-implant CT Dosimetry? Permanent Prostate Brachytherapy Postimplant MRI Dosimetry Using positive contrast MRI markers. Int J Radiat Oncol Biol Phys 96(2S):E280-1, 2016.
29. Frank SJ, Pugh TJ, Mahmood U, Blanchard P, Kudchadker R, Graber W, Kuban DA, Choi S, Hoffman KE, McGuire SE, Chen HC, Wang X, Thaker NG, Bruno T, Henry TG, Occena MC, Kaplan RS, Feeley TW, Swanson D. The Value of Brachytherapy for Intermediate-Risk Localized Prostate Cancer Using Ichom Outcomes and Time-Driven Activity-Based Costing: Results From a Phase 2 Prospective Trial of 300 Patients. Int J Radiat Oncol Biol Phys 96(2S):E400-E401, 2016.
30. Choi S, Levy LB, Lee KK, Nguyen QN, Lee AK, McGuire SE, Kudchadker R, Du W, Hoffman KE, Mahmood U, Frank SJ, Kuban DA. Identifying a Subgroup of High-Risk Prostate Cancer Patients With Worse Clinical Outcomes: Should There Be a "Very High-Risk" Group?. Int J Radiat Oncl Biol Phys 96(2S):E240-E241, 2016.
31. Yu J, Gong Y, Yuan L, Xue C, Chen W, Giaddui TG, Wu QR, Lukka H, Kudchadker R, Seaward SA, Gopaul DD, Michalski JM, Kaplan ID, Beliveau-Nadeau D, Stall BR, Beyer DC, Ma CM, Dayes IS, Pinover WH, Xiao Y. Investigation Into the Feasibility of Having Uniform Compliance Dosimetric Criteria Across Radiation Therapy Treatment Modalities for NRG Oncology/RTOG 0938 by Using Machine Learning. Int J Radiat Oncl Biol Phys 96(2S):E230-E231, 2016.
32. Hoffman KE, Voong KR, Levy LB, Pugh TJ, Choi S, Du W, Frank SJ, Johnson JL, Kudchadker R, Nguyen QN, Lee A, Mahmood U, McGuire SE, Kuban DA.. Randomized Trial of Hypofractionated Dose-Escalated Intensity Modulated Radiation Therapy Versus Conventionally Fractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 96(2S):S32, 2016.
33. Frank S, Pugh T, Blanchard P, Mahmood U, Graber W, Kudchadker R, Chang H, Wang X, Bruno T, Henry T, Occena M, Swanson D. Permanent seed implantation prostate brachytherapy for intermediate risk prostate cancer: Efficacy and toxicity outcomes from a prospective cohort of 300 patients. Brachytherapy 15(1S):S201, 2016.
34. Blanchard P, Pugh TJ, Swanson DA, Mahmood UX, Chang HC, Wang X, Graber WJ, Kudchadker RJ, Bruno T, Occena MC, Henry TG, Frank SJ.. Prospective cohort of permanent seed implantation prostate brachytherapy for intermediate risk prostate cancer: Patient reported outcomes and comparison of toxicity profiles between 125-iodine, 131-cesium and 103-palladium. Brachytherapy 15(1S):S26, 2016.
35. Blanchard P, Pugh T, Mahmood U, Swanson D, Graber W, Wang J, Bathala T, Lim T, Bruno T, Martin G, Kudchadker R, Frank S. MRI simulation for LDR prostate brachytherapy: Can we replace ultrasound with MRI for treatment planning? Comparison of pre-planning, Day 0 and Day 30 MR dosimetry. Brachytherapy 15(1S):S57, 2016.
36. Cardenas C, Nitsch P, Kudchadker R, Howell R, Kry S. Characterization of Electron Beam Out-Of-Field Doses and Neutron Contamination from Modern Varian and Elekta Linear Accelerators. Med Phys 43(6):3849-3850, 2016.
37. Yan Y, Yang J, Beddar S, Ibbott G, Balter P, Kudchadker R, Krishnan S, Fuller D, Wang J. Dosimetric Impact of MR Image Distortion in Treatment Planning. Med Phys 43(6,Part 11):3446, 2016.
38. Thaker NG, Agarwal A, Pugh TJ, Mahmood U, Guzman AB, Incalcaterra JR, Bathala TK, Kaplan RS, Kudchadker R, Bingham J, Das P, Kuban DA, Buchholz TA, Feeley TW, Frank SJ. Quality improvement in prostate brachytherapy using time driven activity based costing. Int J Radiat Oncol Biol Phys 93(3S):E503, 2015.
39. Cardenas C, Nitsch P, Kudchadker R, Howell R, Kry S. An evaluation of out-of-field doses for electron beams from modern varian and elekta linear accelerators. Med Phys 42(6,Part 35):3637, 2015.
40. Alsanea F, Wootton L, Kudchadker R, Usama M, Beddar S. In vivo skin dosimetry using the exradin W1 plastic scintillation detector for passively scattered proton beam therapy. Med Phys 42(6):3446, 2015.
41. Lim T, Wang J, Frank S, Stafford R, Bruno T, Bathala T, Mahmood U, Pugh T, Ibbott G, Kudchadker RJ. MR protocol development to visualize sirius MRI markers in prostate brachytherapy patients for MRI based post imlant dosimetry. Med Phys 42(6,Part 10):3314-3315, 2015.
42. Wang J, Lim TY, Kudchadker RJ, Pugh TJ, Ibbott G, Frank SJ. Evaluation of MR image distortion in positive contrast markers for low-dose prostate brachytherapy. Brachytherapy 14(1S):S53, 2015.
43. Lim TY, Kudchadker RJ, Wang J, Stafford J, Bruno TL, Bathala TK, Mahmood U, Pugh TJ, Ibbott G, Frank SJ. Initial patient experience with positive-contrast MRI markers for low-dose rate prostate brachytherapy. Brachy 14(Suppl):S35, 2015.
44. Lim T, Wang J, Kudchadker R, Stafford J, Bathala T, Pugh T, Ibbott G, Frank S. Sirius MRI markers for prostate post-implant assessment: MR protocol development. Med Phys 41(6):99, 2014.
45. Cheung JP, Dong, L, Park P, Zhu XR, Kudchadker RJ, Frank SJ, Court LE. Successes and limitations of online range adaptive spot scanning proton therapy for NSCLC. Med Phys 41(6,Part 32):551-552, 2014. e-Pub 2014.
46. Du W, Cho S, Zhang X, Hoffman K, Kudchadker RJ. Decoding the beam complexity in intensity-modulated radiation therapy plans. Med Phys 41(6,Part 17):305, 2014.
47. Wootton L, Kudchadker RJ, Lee A, Beddar S. Results from a 5 patient in vivo rectal wall dosimetry study using plastic scintillation detectors. Med Phys 41(6,Part 2):96, 2014. e-Pub 2014.
48. Thaker NG, Kudchadker RJ, Swanson DA, Albert JA, Mahmood U, Pugh TJ, Boehling NS, Bruno TL, Frank SJ. A phantom based simulator approach to improving the quality of prostate brachytherapy training. Oncology 28(4,1S), 2014.
49. Bishop AJ, Levy L, Braccioforte MH, Moran BJ, Crook JM, Van Vulpen M, Grimm P, Swanson DA, Mahmood U, Pugh TJ, Kudchadker RJ, Frank SJ. Evaluating the face of failure: a model to predict prostate cancer recurrences using PSA trends following brachytherapy implant. Oncology 28(1S), 2014.
50. Lim TY, Stafford RJ, Sankaranarayanapillai M, Martirosyan K, Kudchadker R, Frank S. TU‐G‐134‐05: MRI Characteristics of Cobalt Dichloride N‐Acetyl Cysteine (C4) as a Contrast Agent Marker for Prostate Brachytherapy. Med Phys 40(6,Part28):461, 2013.
51. Yu Z, Yang J, Dong L, Zhang Y, Court L, Mourtada F, Tucker S, Klopp A, Eifel P, Kudchadker RJ. Voxel-by-voxel validation of deformable image registration between external beam and intracavitary brachytherapy images using artificial CT images created from patient populations. Med Phys 40(6,Part 2):90, 2013.
52. Du W, Casey K, Kudchadker RJ. Automated analysis of leaf position accuracy for multi-leaf collimator quality assurance. Med Phys 40(6,Part 12):234, 2013.
53. Yock A, Rao A, Dong L, Beadle B, Zhang L, Yang J, Kudchadker R, Court L. Hierarchical clustering and classification improve the prediction of GTV response throughput the course of head and neck IMRT. Med Phys 40(6,Part 10):200, 2013.
54. Cheung J, Court L, Park P, Zhu XR, Frank S, Kudchadker RJ, Dong L. Evaluation of various spot MU correction methods for range adaptive scanning-beam proton planning. Med Phys 40(6,Part 21):359, 2013.
55. Cheung J, Dong L, Park P, Zhu XR, Kudchadker RJ, Frank SJ, Palmer Matthew; Liu W, Court L. Prediction of sensitivity of IMPT plans to anatomical change due to plan complexity. Med Phys 40(6,Part 21):363, 2013.
56. Beddar S, Wootton LS, Kudchadker RJ, Lee AK. Preliminary results of an online patient in-vivo dosimetry protocol to monitor anterior rectal wall dose in real time. 2nd ESTRO Forum 106(2S):S340-S341, 2013.
57. Kudchadker RJ, Wootton LS, Lee AK, Beddar AS. Localization methodology for water-equivalent plastic scintillation detectors using surrogate fiducials in CT. 2nd ESTRO Forum 106(2S):S292-S293, 2013.
58. Kudchadker RJ, Lim T, Du W, Mahmood U, Pugh TJ, Frank SJ. Cesium-131 stranded seed nomogram for a prospective phase II intermediate-risk low dose rate prostate brachytherapy clinical trial. Brachytherapy 12(1S):S73, 2013.
59. Pugh TJ, Kudchadker RJ, Mahmood U, Bruno TL, Frank SJ. Prostate brachytherapy treatment planning using T2 weighted cube 3D magnetic resonance imaging (MRI) without an endorectal coil. Brachytherapy 12(1S):S72, 2013.
60. Lim TY, Frank SJ, Pugh TJ, Bruno TL, Kudchadker RJ. Comparison of two treatment planning systems Variseed and MIM for low dose rate prostate brachytherapy. Brachytherapy 12(1S):S68, 2013.
61. Beddar AS, Wootton LS, Kudchadker RJ, Choi S, Pugh T, Lee AK. Online in-vivo dosimetry of rectal dose using plastic scintillation detectors for prostate patients. IEEE Nuclear Science Symposium and Medical Imaging, 2013.
62. Anand A, Kerns J, Du W, Kudchadker RJ. A novel method using Agfa-Kodak computer radiography system for routine quality assurance tests on linear accelerators. Med Phys 39(6,Part 6):3718, 2012.
63. Anand A, Du W, Chung H, Frank SJ, Pugh TJ, Kudchadker RJ. M.D. Anderson prostate seed implant dose calculator. Med Phys 39(6,Part 10):3713, 2012.
64. Yang M, Du W, Frank SJ, Pugh TJ, Bruno TL, Kudchadker RJ. Radiation exposure estimation for 131Cs prostate implant patient release determination. Med Phys 39(6,Part 13):3763, 2012. PMID: 28517343.
65. Yu Z, Klopp A, Kudchadker R, Mourtada F, Eifel P, Park P, Dong L. A universal margin reconstruction method for estimating anatomy induced proton range uncertainties. Med Phys 39(6,Part 23):3904, 2012.
66. Cheung J, Park P, Zhu X, Frank SJ, Court L, Kudchadker R, Dong L. Feasibility of online range adaptive spot scanning proton therapy. Med Phys 39(6,Part 30):3998, 2012.
67. Du W, Gao S, Wang X, Kudchadker RJ. Evaluating gantry sag on linear accelerators and introducing an MLC based compensation strategy. Med Phys 39(6,Part 11):3722, 2012. PMID: 28517157.
68. Klein DM, Wootton LS, Kudchadker RJ, Lee AK, Beddar AS. In-phantom dose verification of four-field box and IMRT treatment delivery using plastic scintillation detectors. Radiother Oncol 103(2S):S126-S127, 2012.
69. Pugh TJ, Swanson DA, Kudchadker RJ, Bruno TL, Munsell MF, Frank SJ. Prospective evaluation of pharmacologic penile rehabilitation following prostate brachytherapy. Radiother Oncol 103(2S):S91-S92, 2012.
70. Frank SJ, Madden T, Swanson DA, Martirosyan K, Uthamanthil R, Stafford J, Gagea M, Pugh TJ, Kudchadker RJ, Johansen MJ. C4 markers for MRI-based prostate brachytherapy. Radiother Oncol 103(2S):S91, 2012.
71. Christensen EN, Pugh TJ, Munsell MF, Swanson DA, Kudchadker RJ, Bruno TL, Brown AP, Frank SJ. Sector Analysis of Prostate Brachytherapy Shows That Low Doses can Achieve an Undetectable PSA. Int J Radiat Oncol Biol Phys 81(2S):S422, 2011.
72. Kudchadker RJ, Du W, Bruno TL, Pugh TJ, Frank SJ. Treatment planning dosimetry comparison between model 9011 I-125 thinseed and Model 6711 I-125 seeds for prostate brachytherapy. Med Phys 38(6,Part 20):3625, 2011. e-Pub 2011.
73. Cheung JP, Park PC, Zhu XR, Court LE, Frank SJ, Kudchadker RJ, Dong L. Comparison of dosimetric benefit of online dose-guided alignment versus anatomy guided alignment for proton therapy. Med Phys 38(6):3854, 2011.
74. Kudchadker RJ, Pugh TJ, Bruno TL, Du W, Swanson DA, Frank SJ. Optimizing quality assurance in a prospective phase II clinical trial for intermediate risk prostate cancer with brachytherapy as monotherapy using a Palladium-103 stranded seed nomogram. Med Phys 38(6):3625, 2011.
75. Wootton LS, Zhu XR, Kudchadker RJ, Sharma RJ, Choi B, Taylor MB, Dong L, Johnson JL, Nguyen QN, Choi S, Lee AK. Comparison of fiducial and bony-anatomy based alignment for prostate localization in proton therapy. Med Phys 38(6,Part 18):3609, 2011.
76. Frank SJ, Munsell MF, Pugh TJ, Kudchadker RJ, Bruno TL, Swanson DA. Long-term outcomes, quality of life, and patient-reported satisfaction following prostate brachytherapy: The MD Anderson cancer center experience. Brachytherapy 10(1S):S16-S17, 2011.
77. Pugh TJ, Frank SJ, Kudchadker RJ, Swanson DA, Davis JW. Prostate MRI in men with intermediate risk prostate cancer: Implications for prostate brachytherapy monotherapy. Brachytherapy 10(1S):S30, 2011.
78. Morikawa LK, Kudchadker R, Kanke J, Oyervides M, Frank S, Lee AK, Hoffman K, Choi S, Nguyen Q, Kuban DA. Endorectal Balloon in Post-Operative Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 78(3S):S395, 2010.
79. Choi S, Johnson JL, Kudchadker RJ, Dong L, Lee AK. Analysis of Fiducial Migration for Prostate Cancer Patients undergoing Image-Guided Radiation Therapy (IGRT). Int J Radiat Oncol Biol Phys 78(3S):S676, 2010.
80. Zhang M, Munsell MF, Swanson DA, Kudchadker RJ, Albert JM, Urbauer DL, Kuban DA, Bruno TL, Frank SJ. Patients Can Expect Long-term Satisfaction After Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 78(3S):S367, 2010.
81. Albert JM, Zhang M, Bruno TL, Kudchadker RJ, Swanson DA, Frank SJ. MRI-Based Treatment Planning for Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 78(3S):S372-S373, 2010.
82. Kudchadker RJ, Swanson D, Bruno T, Frank SJ. Real-Time Intraoperative Planning Is Not Required to Achieve Consistent High Quality Implants for Prostate Brachytherapy. Med Phys 37(6,Part 16):3204, 2010.
83. Kudchadker RJ, Nguyen Q, Vu K, Wootton L, Vassiliev O, Choi S, Frank S, Johnson J, Kuban D, Lee AK. Dosimetric Evaluation of the Use of Air or Water Filled Endorectal Balloons for Prostate IMRT Patients. Med Phys 37(6,Part 18):3225, 2010.
84. Melancon A, Lee A, Kudchadker R, Titt U, Beddar S, Zhu X, Dong L. Range Adaptive Proton Therapy for Prostate Cancer. Med Phys 37(6,Part 9):3332, 2010.
85. Frank SJ, Register SP, Levy L, Kudchadker RJ, Bruno TL, Swanson DA.. An MRI dose response analysis for urinary morbidity following prostate brachytherapy monotherapy in a phase II prospective trial. Brachytherapy 9(2):S42, 2010.
86. Morikawa L, Kudchadker RJ, Kanke J, Choi S, Nguyen Q, McGuire S, Hoffman K, Frank S, Lee A, Kuban D. Endorectal Balloon in Post-operative Prostate Cancer Patients: Who benefits from it?. Jornada Paulista de Radiologia, 2010.
87. Sharp HJ, Swanson DA, Zhang M, Phan J, Bruno TL, Kudchadker RJ, Kuban DA, Lee AK, Choi S, Nguyen Q, Frank SJ. Prostate brachytherapy preceded by screening colonoscopy diagnosis colorectal cancers in asymptomatic patients. Proceedings of the American Radium Society 92nd Annual Meeting:46, 2010.
88. Shirvani SM, Kudchadker RJ, Bruno TL, Swanson DA, Frank SJ. Letting the catheter out of the bag:The effect of urinary catheterization on post-implant dosimetry after prostate brachytherapy with Palladium-103. Proceedings of the American Radium Society 92nd Annual Meeting:49, 2010.
89. Nguyen QN, Kudchadker RJ, Vu K, Wootton LS, Levy L, Choi S, Johnson JL, Frank SJ, Kuban DA, Lee AK. Rectal sparing with utilization of an endo-rectal balloon for prostate patients treated with an IMRT technique. Proceedings of the American Radium Society 92nd Annual Meeting:53, 2010.
90. Kudchadker RJ, Li H, Johnson JL, Lee AK.. Imaging study to determine appropriate implanted fiducial markers for proton or photon image guided radiation therapy. Med Phys 36(6,Part 6):2485, 2009.
91. Li H, Lee AK, Zhu XR, Kudchadker RJ.. The effect of treatment couch attenuation on radiation dose for megavoltage photon beams. Med Phys 36(6,Part 12):2580, 2009.
92. Vassiliev ON, Kudchadker RJ, Kuban DA, Lee AK.. Dosimetric impact of gold fiducial markers in patients undergoing external beam radiation therapy. Med Phys 36(6,Part 6):2491-2492, 2009.
93. Melancon AD, Archambault L, Lee AK, Kudchadker RJ, Zhang L, Beddar S, Titt U, Dong L.. In vivo detection of the anterior rectal wall using a scintillating fluid-filled rectal balloon for prostate cancer radiotherapy. Med Phys 36(6):2431, 2009.
94. Frank SJ, Tailor R, Martirosyan K, Stafford J, Swanson D, Sing D, Choi J, Elliot A, Mourtada F, Kudchadker R, Ibbott G.. C4 MRI ECAMS have no effect on 125I seed anisotropy and are visible after radiation exposure. Brachytherapy 8(2):172, 2009.
95. Whaley JT, Levy LB, Swanson DA, Kudchadker RJ, Bruno TL, Frank SJ.. Sexual outcomes unaffected by penile bulb dose in prostate brachytherapy. Brachytherapy 8(2):173, 2009.
96. Johnson JL, Kudchadker RJ, Dong L, Lee AK. Comparison of prostate localization methods: CT-prostate, CT-bone, intraprostatic fiducials and ultrasound guidance. Int J Radiat Oncol Biol Phys 72(1):S572-S573, 2008. e-Pub 2008.
97. Vassiliev O, Kudchadker RJ, Swanson DA, Kuban DA, Bruno T, Frank SJ.. Systematic evaluation of periurethral stranded seed migration and its dosimetric consequences in prostate brachytherapy. Int J Radiat Oncol Biol Phys 72(1S):S582, 2008.
98. Kudchadker RJ, Schinkel CG, Choi S, Lee AK.. Use of a hand-held bladder scanner to achieve a reproducible daily bladder volume for proton irradiation of the prostate. Int J Radiat Oncol Biol Phys 72(1):S575, 2008. e-Pub 2008.
99. Cheung M, Kudchadker R, Choi H, Ma J, Kuban D.. Assessing the accuracy of contour-guided diffeomorphic deformable registration of intraprostatic tumor in endorectal MRI. Int J Radiat Oncol Biol Phys 72(1):S569, 2008.
100. Lee AK, Kudchadker RJ, Choi B, Choi S, Bluett J, Zhu R, Dong L.. The effectiveness of rectal balloon and orthogonal imaging for proton therapy of prostate cancer. Int J Radiat Oncol Biol Phys 72(1):S553-S554, 2008.
101. Weinberg R, Antolak JA, Hogstrom KR, Starkschall G, Kudchadker RJ, White RA, Oh JL.. Electron intensity modulation with multileaf collimation for mixed-beam partial breast irradiation. Int J Radiat Oncol Biol Phys 72(1):S527, 2008.
102. Frank SJ, Fisher C, Levy L, Kudchadker RJ, Kuban DA, Lee AK, Cheung M, Choi S, Bruno T, Swanson DA.. Pre-implant urinary symptoms predict for worse urinary outcomes. Int J Radiat Oncol Biol Phys 72(1):S502, 2008. e-Pub 2008.
103. Sejpal SV, Amos RA, Bluett JB, Levy LB, Kudchadker RJ, Johnson J, Choi S, Lee AK.. Evaluation of dose changes to target and critical structures from rotational setup errors (RSE) in prostate cancer patients treated with proton therapy. Int J Radiat Oncol Biol Phys 72(1):S321, 2008. e-Pub 2008.
104. Weinberg R, Antolak J, Starkschall G, Kudchadker R, Hogstrom K.. Electron intensity modulation for mixed-beam radiation therapy with an X-Ray multi-leaf collimator. Med Phys 35(6,Part 27):2985, 2008. e-Pub 2008.
105. Melancon A, Lee AK, Kudchadker RJ, Dong L.. Improving rectal sparing with a single anterior proton beam: a planning study. Med Phys 35(6,Part 16):2833, 2008. e-Pub 2008.
106. Schinkel C, Kudchadker RJ, Choi S, Lee AK. Clinical utility of a portable ultrasound bladder scanner in prostate external-beam radiation therapy. Med Phys 35(6):2690, 2008. e-Pub 2008.
107. Phan J, Swanson DA, Kuban DA, Lee AK, Cheung R, Choi S, Kudchadker R, Bruno T, Levy LB, and Frank SJ.. Long-term rectal complications following permanent prostate brachytherapy at the University of Texas M.D. Anderson Cancer Center. Proceedings of the 90th American Radium Society Meeting:40, 2008.
108. Lee AK, Levy L, Dong L, Cheung R, Choi S, Frank S, Johnson J, Kudchadker R, Kuban D. IMRT for prostate cancer: The M.D. Anderson experience. Proceedings of the 90th American Radium Society Meeting:13, 2008.
109. Frank SJ, Kuban DA, Lee AK, Levy LB, Kudchadker R, Bruno T, Swanson DA.. Prostate Brachytherapy – The M.D. Anderson Cancer Center Experience. The Journal of Urology 179(4):396-397, 2008. e-Pub 2008.
110. Frank SJ, Stafford RJ, Bankson JA, Li C, Swanson DA, Kudchadker RJ, Martirosyan KS.. A novel MRI-based approach to prostate brachytherapy. Brachytherapy 7(2):101-102, 2008.
111. Lee AK, Kudchadker RJ, Amos RA, Johnson JL, Choi SL, Kuban DA, Cox JD, Mohan R, Gillin M, Dong L. Proton therapy vs. IMRT for prostate cancer: A dosimetric comparison. Int J Radiat Oncol Biol Phys 69(3):S342, 2007.
112. Sahoo N, Zhu XR, Zhu M, Amos R, Kudchadker RJ, Johnson J, Arjomandy B, Lii M, Wu R, Gillin MT. Analysis of the accuracy of a monitor unit calculation procedure for passively scattered proton therapy beams. Int J Radiat Oncol Biol Phys 69(3):S689-S690, 2007.
113. Nelson C, Balter P, Choi B, Vedam S, Lindsay P, Kudchadker R, Briere T, Chang J, Morice R and Starkschall G. Improvement in the daily alignment of mobile lung tumors using implanted fiducials. Med Phys 34(6,Part 1):2328, 2007.
114. Starkschall G, Beddar S, Johnson J, Kudchadker R, Lawyer A , Tung S, Zhang S. Use of a website for support of a clinical rotation in radiation oncology physics. Med Phys 34(6,Part 7):2400, 2007.
115. Balter P, Lindsay P, Kudchadker R, Nelson C, T Briere, Vedam S, Komaki R and Mohan R. A comparison of a point based tool with an image overlay tool for fiducial based setup. Med Phys 34(6):2372, 2007.
116. Lindsday P, Choi B, Bucci M, Zhang L, Dong L, Kudchadker R, Zhu X and Balter P.. Comparison of image registration tools used for daily KV imaging-based patient setup. Med Phys 34(6,Part 5):2375, 2007.
117. Melancon A, Dong L, Kudchadker R, Amos R, Johnson J, Zhang Y, Yu Z, Zhang L and Lee A. Evaluation and comparison of inter-fractional femoral head variations for two pelvic immobilization devices. Med Phys 34(6,Part 6):2384, 2007.
118. O'Daniel J, Kudchadker R, Zullo J, Gillin M. Clinical beam tuning of low-energy electron beams: matching Varian and Siemens linear accelerators. Med Phys 34(6,Part 8):2424, 2007.
119. Zullo J, Kudchadker R, Lindsay P, Zhu X and Gillin M. Dose measurement accuracy of TLD-100 in the bragg peak region of a therapeutic proton beam. Med Phys 34(6,Part 9):2439, 2007.
120. Kudchadker R, Johnson J, Bruno T and Frank S. Improved homogeneity with fourth generation prostate brachytherapy implants - A revised I-125 seed nomogram. Med Phys 34(6,Part 11):2459, 2007.
121. Chueng R, Tucker S, de Crevoisier R, Lee A, Frank S, Kudchadker R, Thames H, Mohan R and Kuban D. Identification of the bladder dose and volume constraints to control late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 66(3):S37-S38, 2006.
122. Kudchadker RJ, Ha CS, Stokes C, Kirsner SM, Wilder RB. Breast dose reduction in woman undergoing mediastinal radiotherapy using a custom prone immobilization device. Int J Radiat Oncol Biol Phys 66(3):S679, 2006.
123. Lindsay P, Zhu X, Zhang L, Wu R, Kudchadker R, Salehpour M, Lui R, Mohan R, Gillin M and Dong L. Effect of measured cone-beam CT-density calibration on dose calculations. Med Phys 33(6):2286, 2006.
124. Liengsawangwong, Kudchadker R, Wu R, Session R, Diel T, Aleman G, Dong L, Gillin M and Zhu X. Mechanical, radiation and imaging isocenter quantification on four Varian on-board imager Clinacs. Med Phys 33(6,Part 22):2283, 2006.
125. Zhu XR, Zhang L, Kudchadker R, Wu R, Balter P, Mohan R, Gillin M and Dong L.. Clinical implementation of cone-beam CT for image-guided radiation therapy. Med Phys 33(6,Part 21):2268, 2006.
126. O’Daniel J, Dong L, Zhang L, Wang H, Tucker S, Kudchadker R, de Crevoisier R, Lee A, Cheung R, Cox J, Kuban D, Mohan R. Dosimetric comparison of the no action level alignment protocol with daily alignment techniques for prostate cancer. Med Phys 33(6,Part 20):2253-2254, 2006.
127. Melancon A, Dong L, de Crevoisier R, O'Daniel J, Kudchadker R, Newhauser W. Tucker S. Lee A, Cheung R, Mohan R, Kuban D. The dosimetric impact of intrafractional motion on IMRT treatment of prostate cancer. Med Phys 33(6,Part 16):2187-2188, 2006.
128. Kudchadker R, Tolani N, Luo D, Kendall R, Mason B, Steadham R, Kanke J, Rosen I, Gillin M, Prado K. Evaluation and commissioning of K&S Associates Inc. Diamond monitor unit calculation software. Med Phys 33(6,Part 10):2098, 2006.
129. Johnson J, Lee A, Kudchadker , Amos R, Frank S, Cheung R, Kuban D, Dong L. Comparison of prostate implanted fiducial with CT and ultrasound for prostate target localization: Initial results. Med Phys 33(6):2029, 2006.
130. Kudchadker R, Zhu X, Zhang L, Lee A, Mohan R, Gillin M and Dong L. Implementation of on-board imager for daily image-guided radiation therapy in a multi vendor environment. Med Phys 33(6,Part 5):2038, 2006. e-Pub 2006.
131. Weinberg R, Antolak J, Hogstrom K, Starkschall G, Kudchadker R, Mohan R. Influence of initial pencil beam parameters on large non-applicator electron field profiles calculated using Monte Carlo methods. Med Phys 32(6,Part 11):2012, 2005. e-Pub 2005.
132. Weinberg R, Antolak J, Hogstrom K, Starkschall G, Kudchadker R, McNeese M, Tucker S. Mixed-beam therapy and intensity-modulated x-ray therapy: A comparative treatment planning study for head and neck cancer. Med Phys 31:1750-1751, 2004.
133. Weinberg R, Kudchadker R, Antolak J, Morrison W, Hogstrom K. Electron Conformal Therapy as an Alternative to IMXT in the Treatment of Head and Neck Cancer. Med Phys 30:518, 2003.
134. Kudchadker R, Antolak J, Morrison W, Hogstrom K. Conformal head and neck radiotherapy using custom electron bolus. Med Phys 29:1337, 2002.
135. Prado K, Kirsner S, Kudchadker R, Steadham R, Lane R. Estimation of off-axis asymmetric-field enhanced dynamic wedge factors. Med Phys 29:1202, 2002.
136. Kudchadker R, Hogstrom K, Boyd R. Multileaf collimation for electron intensity modulation. IEEE, 2000. e-Pub 2002.
137. Gao S, Muruganandham M, Du W, Ohrt J, Kudchadker R, Balter P. Customize electron energy beams on TrueBeam linear accelerators. Medical Physics.

Book Chapters

1. Abu-gheida I, Moreno AC, Tang C, Kudchadker R, Wang J, Frank SJ. Low dose rate brachytherapy: uses and advanced MRI techniques in prostate cancer. In: Radiation therapy for genitourinary malignancies - A practical and technical guide. 1. Springer: Switzerland, 105-127, 2021.
2. Moreno A, Kudchadker R, Wang J, Frank S. Image guided LDR brachytherapy for prostate cancer. In: Image Guided Brachytherapy Handbook. 1. Springer International Publishing AG: Switzerland, 319-344, 2017.
3. Hogstrom K, Antolak J, Kudchadker R, Ma C, Leavitt D. Modulated Electron Therapy. In: Intensity Modulated Radiation Therapy. 1. Medical Physics Publishing: Madison, WI, 749-786, 2003.
4. Lee C, Zhou X, Hamm R, Harmon F, Kudchadker R, Harker Y. Temperature Rise in Lithium Targets for Accelerator based BNCT Using Multi-Fin Heat Removal. In: Applications of Accelerators in Research and Industry. 1. American Institute of Physics Publishing: Meliville, NY, 1041-1044, 1999.
5. Lee C, Kudchadker R, Harmon F, Zhou Z, Harker Y. Feasibility of a Near-Threshold BNCT Neutron Source Based on Phantom Dosimetry. In: Frontiers in Neutron Capture Therapy. 1. Kluwer Academic / Plenum Publishers: New York, 509-514, 1998.
6. Harmon F, Kudchadker R, Kunze J, Serrano S, Zhou X, Harker Y, Hamm R. Accelerator neutron sources for neutron capture therapy using near threshold charged particle reactions. In: Applications of Accelerators in Research and Industry. 1. American Institute of Physics Publishers, 1285-1288, 1997.
7. Kudchadker R, Kunze J, Harmon F. Balancing neutron yield and moderator dimensions in accelerator neutron sources. In: Advances in Neutron Capture Therapy, Medicine and Physics. 1. Elsevier Publishers, Amsterdam-New York: London, United Kingdom, 516-521, 1997.
8. Kunze J, Kudchadker R, Luo J, Lo Y, Harmon J. Results of benchmark experiment of accelerator/moderator configuration for BNCT-using a RFQ accelerator. In: Accelerator-Based Neutron Sources for Boron Neutron Capture Therapy, 243-253, 1994.